Abstract
Overview of the Safety Profile from Efgartigimod Clinical Trials in Participants with Diverse IgG-Mediated Autoimmune Diseases (P1-5.001)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have